Status:
COMPLETED
Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy
Lead Sponsor:
University of Miami
Conditions:
Bladder Cancer
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Intracorporeal urinary diversion (ICD) provides superior postoperative outcomes compared to extracorporeal urinary diversion (ECD). The investigators' hypothesis that ICD may provide clinical benefit ...
Eligibility Criteria
Inclusion
- Biopsy-proven urothelial cancer being considered for RARC.
- Clinical stage T1-T4, N0-1, M0 or refractory carcinoma in situ.
- Subject must be already scheduled to have a RARC at the discretion of the surgeon and with the patient's agreement.
Exclusion
- Inability to give informed consent
- Prior major abdominal and pelvic open surgical procedures that would preclude a safe robotic approach, as determined by the treating surgeon.
- At the discretion of the treating surgeon, any pre-existing condition such as severe chronic obstructive pulmonary disease that precludes a safe initiation or maintenance of pneumoperitoneum over a prolonged period of time and during surgery.
- Age \<18 or \>99 years.
Key Trial Info
Start Date :
April 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 11 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03469362
Start Date
April 25 2018
End Date
September 11 2024
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136